Our findings demonstrated that mRNA vaccine (BNT162b2) effectively induced antigen-specific CD4+ and CD8+ memory T cells, as well as anti-RBD IgGs and neutralizing antibodies in all vaccinees regardless of the presence of type 2 diabetes. The gene discussed is CD8A; the disease is type 2 diabetes mellitus.